SAFETY AND EFFICACY OF RITUXIMAB IN ADULT WITH CHRONIC IMMUNE THROMBOCYTOPENIA

被引:0
|
作者
Biagiotti, C. [1 ]
Carrai, V. [1 ]
Bacchiarri, F. [1 ]
Alterini, R. [1 ]
Rigacci, L. [1 ]
Antonioli, E. [1 ]
Di Gioia, M. [1 ]
Raugei, G. [1 ]
Bosi, A. [1 ]
机构
[1] Careggi Hosp, Hematol, Florence, Italy
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P176
引用
收藏
页码:124 / 124
页数:1
相关论文
共 50 条
  • [41] RITUXIMAB VERSUS SPLENECTOMY IN PERSISTENT OR CHRONIC ADULT PRIMARY IMMUNE THROMBOCYTOPENIA: AN ADJUSTED COMPARISON OF MORTALITY AND MORBIDITY
    Moulis, G.
    Sailler, L.
    Sommet, A.
    Lapeyre-Mestre, M.
    Adoue, D.
    HAEMATOLOGICA, 2013, 98 : 197 - 198
  • [42] RITUXIMAB THERAPY FOR ADULTS WITH CHRONIC AND REFRACTORY PRIMARY IMMUNE THROMBOCYTOPENIA
    Moldovianu, A. M.
    HAEMATOLOGICA, 2012, 97 : 689 - 690
  • [43] Rituximab versus splenectomy in persistent or chronic adult primary immune thrombocytopenia: an adjusted comparison of mortality and morbidity
    Moulis, Guillaume
    Sailler, Laurent
    Sommet, Agnes
    Lapeyre-Mestre, Maryse
    Derumeaux, Helene
    Adoue, Daniel
    AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (01) : 41 - 46
  • [44] Fostamatinib for persistent/chronic adult immune thrombocytopenia
    Newland, Adrian
    Lee, Eun-Ju
    McDonald, Vickie
    Bussel, James B.
    IMMUNOTHERAPY, 2018, 10 (01) : 9 - 25
  • [45] Efficacy, safety and immunological profile of combining rituximab with belimumab for adults with persistent or chronic immune thrombocytopenia: results from a prospective phase IIb trial
    Mahevas, Matthieu
    Azzaoui, Imane
    Crickx, Etienne
    Canoui-Poitrine, Florence
    Gobert, Delphine
    Languille, Laetitia
    Limal, Nicolas
    Guillaud, Constance
    Croisille, Laure
    Jeljeli, Mohamed
    Batteux, Frederic
    Baloul, Samia
    Fain, Olivier
    Pirenne, France
    Weill, Jean -Claude
    Reynaud, Claude-Agnes
    Godeau, Bertrand
    Michel, Marc
    HAEMATOLOGICA, 2021, 106 (09) : 2449 - 2457
  • [46] Long-term efficacy and safety profile of splenectomy for pediatric chronic immune thrombocytopenia
    Isshiki, Kyohei
    Mori, Makiko
    Irikura, Tomoya
    Ishikawa, Takahiro
    Honda, Mamoru
    Kaneko, Ryota
    Mitani, Yuichi
    Kubota, Hirohito
    Fukuoka, Kohei
    Oshima, Koichi
    Arakawa, Yuki
    Koh, Katsuyoshi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2023, 117 (05) : 774 - 780
  • [47] Efficacy and Safety of Biosimilar Romiplostim Versus Innovator Romiplostim in Patients with Chronic Immune Thrombocytopenia
    S. Chandrakala
    Manoj Toshniwal
    Mitesh Halvawala
    Namita Padwal
    Neeraj Sidharthan
    Pankaj Malhotra
    B. Prashantha
    Riya Ballikar
    Sandip Shah
    Shashikant Apte
    T. Kasi Viswanathan
    Vijay Ramanan
    Akhilesh Sharma
    Dattatray Pawar
    Roshan Pawar
    Vinayaka Shahavi
    Indian Journal of Hematology and Blood Transfusion, 2023, 39 : 435 - 441
  • [48] Long-term efficacy and safety profile of splenectomy for pediatric chronic immune thrombocytopenia
    Kyohei Isshiki
    Makiko Mori
    Tomoya Irikura
    Takahiro Ishikawa
    Mamoru Honda
    Ryota Kaneko
    Yuichi Mitani
    Hirohito Kubota
    Kohei Fukuoka
    Koichi Oshima
    Yuki Arakawa
    Katsuyoshi Koh
    International Journal of Hematology, 2023, 117 : 774 - 780
  • [49] Long-term treatment with romiplostim in patients with chronic immune thrombocytopenia: safety and efficacy
    Kuter, David J.
    Bussel, James B.
    Newland, Adrian
    Baker, Ross I.
    Lyons, Roger M.
    Wasser, Jeffrey
    Viallard, Jean-Francois
    Macik, Gail
    Rummel, Mathias
    Nie, Kun
    Jun, Susie
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 161 (03) : 411 - 423
  • [50] Low-dose rituximab in adult patients with primary immune thrombocytopenia
    Zaja, Francesco
    Vianelli, Nicola
    Volpetti, Stefano
    Battista, Marta Lisa
    Defina, Marzia
    Palmieri, Salvatore
    Bocchia, Monica
    Medeot, Marta
    De Luca, Stefano
    Ferrara, Felicetto
    Isola, Miriam
    Baccarani, Michele
    Fanin, Renato
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2010, 85 (04) : 329 - 334